Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2324]
News [5462]
Articles [134]
Editorials [4]
Conferences [158]
elearning [13]
T cell immunotherapy for leukaemia in preclinical setting
Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
T cell immunotherapy for leukaemia in preclinical setting ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
17 Dec 2013
Idelalisib and rituximab for previously treated chronic lymphocytic leukaemia...
Dr Richard Furman - New York Weill Cornell Medical Center, USA
Idelalisib and rituximab for previously treated chronic lymphocytic leukaemia (CLL) ( Dr Richard Furman - New York Weill Cornell Medical Center, USA )
17 Dec 2013
New agents in CLL
Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA
New agents in CLL ( Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA )
13 Dec 2013
Chronic lymphocytic leukaemia: A new treatment era is born
Dr John Gribben - Barts Cancer Institute, London, UK
Chronic lymphocytic leukaemia: A new treatment era is born ( Dr John Gribben - Barts Cancer Institute, London, UK )
13 Dec 2013
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and...
Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3 ( Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA )
8 Dec 2013
Study of the efficacy and safety of siltuximab, an anti-interleukin-6...
Dr Raymond Wong - Chinese University of Hong Kong
Study of the efficacy and safety of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with multicentric Castleman’s disease ( Dr Raymond Wong - Chinese University of Hong Kong )
8 Dec 2013
Results from the randomised phase III Children’s Oncology Group (COG) trial...
Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA
Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531 ( Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA )
8 Dec 2013
Final stage II results of the CLL11 trial
Dr Valentin Goede - University of Cologne, Germany
Final stage II results of the CLL11 trial ( Dr Valentin Goede - University of Cologne, Germany )
8 Dec 2013
Multidisciplinary in cancer care in India
Dr Harit Chaturavadi - Max Institute of Oncology, New Delhi, India
Multidisciplinary in cancer care in India ( Dr Harit Chaturavadi - Max Institute of Oncology, New Delhi, India )
5 Dec 2013
Goals of 1st Indian Cancer Congress
Dr Ashok K. Vaid - Medanta The Medicity, Haryana, India
Goals of 1st Indian Cancer Congress ( Dr Ashok K. Vaid - Medanta The Medicity, Haryana, India )
5 Dec 2013
Plurality of cancer
Dr Raghunadharao Digumarti - Nizam's Institute of Medical Sciences, Hyderabad...
Plurality of cancer ( Dr Raghunadharao Digumarti - Nizam's Institute of Medical Sciences, Hyderabad, India )
5 Dec 2013
Recent advances in surgery, radiotherapy and targeted treatment for cervical...
Dr Raj Kerkar - Tata Memorial Hospital, Mumbai, India
Recent advances in surgery, radiotherapy and targeted treatment for cervical cancer ( Dr Raj Kerkar - Tata Memorial Hospital, Mumbai, India )
4 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation